期刊文献+

2016年上海市某院分离细菌的分布及耐药性监测 被引量:3

Distribution and antimicrobial resistance profile of clinical bacterial strains isolated from one hospital of Shanghai in 2016
下载PDF
导出
摘要 目的了解2016年上海市某院临床常见标本中细菌的分布和耐药性变迁,为临床合理使用抗菌药物提供依据。方法收集2016年1-12月上海市宝山区中西医结合医院患者标本分离的细菌,按CLSI M100-S26标准判断结果,采用WHONET5.6软件对数据进行统计分析。结果 1 920株非重复分离菌中革兰阴性菌1 385株,占72.14%;革兰阳性菌535株,占27.86%。葡萄球菌属中未发现对万古霉素、利奈唑胺耐药的菌株。耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)检出率分别为56.16%和63.41%。屎肠球菌对多数抗菌药物耐药率高于粪肠球菌。发现1株耐万古霉素的屎肠球菌。大肠埃希菌和肺炎克雷伯菌中产超广谱β-内酰胺酶(ESBLs)的检出率分别为42.06%(106/252)、45.39%(143/315),产ESBLs菌株对大多数抗菌药物的耐药率明显高于非产ESBLs菌株。鲍曼不动杆菌对碳青霉烯类药物的耐药率达60%以上,铜绿假单胞菌对阿米卡星、哌拉西林/他唑巴坦、头孢他啶的敏感率分别为68.47%、66.30%、37.70%,并检出流感嗜血杆菌47株,其中对复方磺胺甲噁唑的敏感率为40.43%。ICU分离出的肠杆菌科细菌和非发酵细菌的耐药率均高于非ICU分离细菌;分离的细菌对亚胺培南和美罗培南的耐药情况较严重。结论加强细菌耐药率监测,有助于掌握其耐药特点,对临床指导用药的意义非常重要。 Objective To investigate the distribution and antimicrobial resistance of the common clinical specimens,and to provide evidence for the rational use of antibiotics.Methods All the bacterial strains i were analyzed,which were isolated from inpatients in Shanghai Baoshan Integrated Traditional Chinese and Western Medicine Hospital in 2016.Results were analyzed according to CLSI M100-S26,and WHONET5.6 software was used to analyze the drug resistance.Results A total of 1 920 clinical isolated strains were collected,of which gram negative bacteria and gram positive bacteria accounted for 72.14%(1 385/1 920)and 27.86%(535/1 920).No Staphylococcal strains were found resistant to vancomycin and linezolid.Methicillin-resistant Staphylococcus aureus(MRSA)and Methicillin-resistant coagulase-negative Staphylococcus(MRCNS)accounted for 56.16% and 63.14%,respectively.The resistance rates of E.faeciumto most of the drugs tested were much higher than those of E.faecalis.One strain of E.faecium was found resistant to vancomycin.ESBLs were produced in 42.06%(106/252)of E.coli strains and 45.39%(143/315)of Klebsiella isolates,respectively.The resistant rates of ESBLs-producing strains were significantly higher than that of non-ESBLsproducing strains.More than 60% of the Acinetobacter baumannii strains were resistant to carbapenems.The percentages of Pseudomonas aeruginosa sensitive to amikacin,piperacillin-tazobactam and ceftazidime were 68.47%,66.30% and 37.70%,respectively.There were 47 strains of Haemophilus influezae,sensitive rate of which to Trimethoprim/sulfamethoxazole was found to be 40.43%.The drug resistance rates of Enterobacteriaceae and non-fermentative bacteria in ICU were generally higher than strains isolated from non-ICU.Conclusion It is very important to monitor the antibiotic resistance for better control of gram-positive infection and reasonable antibiotic use.
出处 《检验医学与临床》 CAS 2017年第23期3453-3457,3460,共6页 Laboratory Medicine and Clinic
基金 国家自然科学基金资助项目(81272603 81472179) 上海市第四轮公共卫生体系建设三年行动计划(15GWZK0301)
关键词 病原微生物 抗菌药物 灵敏度 耐药性 pathogenic microorganism antibacterials susceptibility drug resistance
  • 相关文献

参考文献4

  • 1胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,韩艳秋,郭素芳,魏莲花,吴玲,张泓,孔菁,胡云建,艾效曼,卓超,苏丹虹.2014年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2015,15(5):401-410. 被引量:722
  • 2张小江,杨启文,孙宏莉,王瑶,王贺,窦红涛,赵颖,王澎,张辉,朱任媛,宋红梅,徐英春.2014年北京协和医院细菌耐药性监测[J].中国感染与化疗杂志,2016,16(3):315-322. 被引量:26
  • 3徐安,卓超,苏丹虹,胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,孙自镛,陈中举,倪语星,孙景勇,胡志东,李金,张朝霞,季萍,王传清,王爱敏,杨青,徐元宏,沈继录,单斌,杜艳,张泓,孔菁,魏莲花,吴玲,谢轶,康梅,胡云建,艾效曼,俞云松,林洁,黄文祥,贾蓓,禇云卓,田素飞,韩艳秋,郭素芳.2005-2014年CHINET克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2016,16(3):267-274. 被引量:122
  • 4沈继录,潘亚萍,徐元宏,倪语星,孙景勇,王传清,王爱敏,徐英春,张小江,汪复,朱德妹,胡付品,蒋晓飞,单斌,杜艳,张泓,孔菁,卓超,苏丹虹,杨青,魏莲花,吴玲,张朝霞,季萍,胡志东,李金,胡云建,艾效曼,谢轶,康梅,俞云松,林洁,孙自镛,陈中举,黄文祥,贾蓓,褚云卓,田素飞,韩艳秋,郭素芳.2005—2014年CHINET大肠埃希菌耐药性监测[J].中国感染与化疗杂志,2016,16(2):129-140. 被引量:118

二级参考文献52

  • 1刘晓强,钟日辉,严海燕.404株大肠埃希菌耐药性变迁分析[J].实用医技杂志,2008,15(32):4531-4533. 被引量:5
  • 2卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:80
  • 3Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24.
  • 5Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136.
  • 6Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120.
  • 7Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase- producing Klebsiella tmeumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58 (4): 2322-2328.
  • 8Tascini C, Jagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin resistant KPC producing Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(8): 3990-3993.
  • 9Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions [J]. Clin Microbiol Rev, 2012, 25(4): 682-707.
  • 10Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility TestingfS].20th informational supplement,2014,M100-S24.

共引文献924

同被引文献16

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部